Selected Publications
Monica Wei, Matthew J. Ziegler, Pam Tolomeo, Laura Cowden, Brendan J. Kelly: k-mer sketch profiles identify suspected multidrug-resistant organism transmission events. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026 (Munich, Germany) April 2026.
Lucky CW, Medernach RL, Kelly BJ, Kwon JH, Woodworth MH.: Microbiome Therapeutics for Clostridioides difficile Infection. Infect Dis Clin North Am 39(4): 663-683, Dec 2025.
Ziegler MJ, Anesi J, Tolomeo P, Glaser L, Cowden L, Cressman L, Huang E, Patel A, Lautenbach E, Pegues DA, Kelly BJ.: Screening and targeted prophylaxis for Clostridioides difficile infection. Clin Microbiol Infect 31(11): 1907-1913, Nov 2025.
Laurel Redding, Scott G. Daniel, Joseph D. Zackular, Maho Okumura, Stephen D. Cole, Kyle Bittinger, Brendan J. Kelly: Amplicon-Based Sequencing is Able to Accurately Detect Clostridioides Difficile. SSRN [preprint] July 2025.
Ziegler MJ, Loughrey S, Bekele S, Huang E, Tolomeo P, David MZ, Lautenbach E, Glaser LJ, Kelly BJ.: Comparative performance of sponge versus flocked swabs for culture-based and metagenomic detection of microbial contamination in the healthcare environment. Infect Control Hosp Epidemiol 46(8): 1-7, May 2025.
Sherrie Xie, Leigh Cressman, Matthew J. Ziegler, Brendan J. Kelly: Impact of time post-hospitalization on carbapenem-resistance among Enterobacterales infections. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2025 (Vienna, Austria) April 2025.
Alyssa Mezochow, Emilia Wilkins, Leigh Cressman, Brendan J. Kelly: Lung pathogens persist in the gut microbiome during critical illness. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2025 (Vienna, Austria) April 2025.
Kelly BJ, Kwon JH, Woodworth MH.: Reply to Olle et al. J Infect Dis 231(2): 545, Feb 2025.
Ziegler MJ, Anesi J, Tolomeo P, Glaser L, Cowden C, Cressman L, Huang E, Patel A, Lautenbach E, Kelly BJ: Screening and targeted prophylaxis for Clostridioides difficile infection: STOP-CDI. Infectious Diseases Society of America, IDWeek. Oral Presentation; 2024 Oct; Los Angeles, CA. October 2024.
Kelly BJ, Kwon JH, Woodworth MH.: Escape Velocity-the Launch of Microbiome Therapies. J Infect Dis 230(30): 2-4, Jul 2024.
back to top
Last updated: 04/20/2026
The Trustees of the University of Pennsylvania